Cary Street Partners Investment Advisory’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-70
Closed -$4.92K 658
2023
Q3
$4.92K Hold
70
﹤0.01% 1482
2023
Q2
$5.58K Hold
70
﹤0.01% 1384
2023
Q1
$5.06K Hold
70
﹤0.01% 1327
2022
Q4
$5.76K Buy
+70
New +$5.77K ﹤0.01% 1300

Other funds holding ACHC

Cary Street Partners Investment Advisory's ACHC Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Acadia Healthcare (ACHC) in Q4 2023, closing a stake of 70 shares — an estimated $4.92K sold.

Cary Street Partners Investment Advisory first reported a position in ACHC in Q4 2022 and held it in 4 quarters. The position peaked at $5.76K in Q4 2022. 313 funds tracked by Wall St. Rank hold ACHC as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Acadia Healthcare position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 70 Acadia Healthcare shares in Q4 2023, an estimated $4.92K.
  • Cary Street Partners Investment Advisory first reported a position in Acadia Healthcare in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Acadia Healthcare position peaked at $5.76K in Q4 2022.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.